Your Location:
Home >
Browse articles >
Anti-liver Cancer Mechanism of Hypericin Based on Network Pharmacology and Molecular Docking
Updated:2022-06-28
    • Anti-liver Cancer Mechanism of Hypericin Based on Network Pharmacology and Molecular Docking

      Enhanced Publication
    • ZHANG Ting , LI Na , SONG Xiaofeng , ZHU Ting
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 15, Pages: 183-191(2022)
    • DOI: 10.13422/j.cnki.syfjx.20220811     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Figs( 3 ) Tabs( 4 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

219

Views

361

Downloads

1

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Distribution Mechanism of Network Modules in Combined Treatment of Liver Cancer with Jiuwei Zhengxiao Granules
An Exploration on Mechanisms of Treating Different Diseases with Same Method of Qinggan Huayu Granules in Treating NAFLD and Liver Cancer Based on Network Pharmacology
Material Basis, Pharmacological Mechanisms, and Quality Control of Antitumor Effect of Cremastrae Pseudobulbus Pleiones Pseudobulbus: A Review
Traditional Chinese Medicine Treatment of Liver Cancer Based on Hippo Signaling Pathway: A Review
Material Basis of Entada phaseoloides Against Neuropathic Pain Based on in vitro Chemical Profiling and in vivo Absorbed Constituents

Related Author

Rong LI
Hao GU
Pengqian WANG
Xuewu LIU
Dongdong PENG
Dejian JIANG
Bo WANG
Jun LIU

Related Institution

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Hunan Key Laboratory of Pharmacodynamics and Safety Evaluation of New Drugs, Hunan Prima Drug Research Center Co. Ltd.
School of Biological Science and Medical Engineering, Beihang University
Beijing University of Chinese Medicine